VAERS Reports U008897

VAERS 2151177

MERCK & CO. INC. · HPV (GARDASIL 9) · Charge U008897

kritisch

Staat: FL
Alter: 16,0
Geschlecht: M
Eingang: 01.03.2022
Impfdatum: 25.02.2022
Beginn: 26.02.2022
Tage bis Beginn: 1,0
Dosis: 2
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Activated partial thromboplastin time shortened Benzodiazepine drug level increased Blood fibrinogen Blood gases Blood pH decreased C-reactive protein increased Chest X-ray abnormal Coma scale Computerised tomogram head normal Cortical dysplasia Culture negative Electroencephalogram abnormal Endotracheal intubation Fibrin D dimer International normalised ratio normal Magnetic resonance imaging head normal Mechanical ventilation N-terminal prohormone brain natriuretic peptide normal

Symptomtext

At 6:50am on 02/26 (approximately 20 hours post immunization) patient was found by parents in bed with active seizures. EMS arrived and found patient with seizures. Transported to Medical Center. On arrival intermittent seizures with Glascow Coma Scale of 3. Electively intubated. Mechanically ventilated for 36 hours. Extubated on 02/27/22

Weitere VAERSDATA-Felder

Praegender Schweregrund: Coma scale
Hospital-Tage: -
Labordaten: Work up shows WBC 31.8k with 45S, 1B, 38L. Platelets 449k. Blood gas shows pH 7.17 with a base deficit of 12.2. PT 12.6. INR 1.1. PTT 39.1. D-Dimer 677. Fibrinogen 352. CRP 1.1. ESR 3. N-Pro NBT 44. Troponin <0.012. UA negative. COVID negative. Cultures negative. Tox screen negative except for benzodiazepine. CXR with possible RML infiltrate. CT scan of the brain negative. MRI of the brain in normal. Continuous video EEG is abnormal due to the presence of intermittent left frontotemporal slowing, often sharply contoured, admixed with the background in awake and sleep states. Findings indicate focal cortical dysfunction in this region.
Aktuelle Erkrankungen: COVID on 01/02/2022. URI symptoms with cough and congestion but no fever the week of 02/21/22
Vorgeschichte: none
Andere Medikamente: none
Allergien: none
Vorherige Impfungen: -

VAERS 2139882

MERCK & CO. INC. · HPV (GARDASIL 9) · Charge U008897

schwer

Staat: FL
Alter: 42,0
Geschlecht: F
Eingang: 25.02.2022
Impfdatum: 22.02.2022
Beginn: 22.02.2022
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Asthenia Dizziness Dyspnoea Feeling abnormal Hyperhidrosis Pain in extremity Peripheral swelling Syncope Tenderness Urticaria Vision blurred

Symptomtext

On 02-22-22 about 5 hours after the vaccine patient experienced weird feelin, sweating, dizziness, blurred vision, then fainted. Someone helped her up, got her something to drink and she sat for 30 mins, then left for home. (She was at work). She felt weak at home, went to bed. Next day in the morning she noticed hives, and took Benadryl. On 02-24-22-the following day her hands were sore, tender and swollen, hives remain the same. No shortness of breath today, had SOB on the first day, did not go to ED. Physician notified, ordered Zyrtec10 mg one daily, Pepcid 20 mg twice daily, Medrol dospak 4 mg

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: Vaginal discharge, Fistula, abnormal vaginal bleeding, migraine
Vorgeschichte: Fibroids, genital herpes, Migraine, mitral valve prolapse, vitamin d deficiency
Andere Medikamente: Valtrex 1 g Daily Multivitamin Nuva Ring Vitamin B complex Vitamin C Vitamin D3 Voltaren gel
Allergien: Oxycontin, Latex
Vorherige Impfungen: -

VAERS 2631619

MERCK & CO. INC. · HPV (GARDASIL 9) · Charge u008897

mild

Staat: TN
Alter: 35,0
Geschlecht: F
Eingang: 13.05.2023
Impfdatum: 26.03.2023
Beginn: 26.03.2023
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Pain Pain in extremity

Symptomtext

Sore arm upon exertion and laying upon the arm. Rates the pain 7/10.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pain
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2502591

MERCK & CO. INC. · HPV (GARDASIL 9) · Charge U008897

mild

Staat: MO
Alter: 43,0
Geschlecht: M
Eingang: 12.11.2022
Impfdatum: 03.11.2022
Beginn: 03.11.2022
Tage bis Beginn: 0,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Immediate post-injection reaction Injection site pain Pain Product administered at inappropriate site

Symptomtext

Site: Pain at Injection Site-Medium

Weitere VAERSDATA-Felder

Praegender Schweregrund: Injection site pain
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2417730

MERCK & CO. INC. · HPV (GARDASIL 9) · Charge U008897

mild

Staat: NV
Alter: 17,0
Geschlecht: M
Eingang: 22.08.2022
Impfdatum: 22.08.2022
Beginn: 22.08.2022
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Cold sweat Feeling cold Nausea Pallor

Symptomtext

2 minutes after immunization patient became pale, cool, clammy and nauseous. No LOC Patient was placed in recovery position to rest. Approx 15 minutes later patient was able to drink water, sit up and ambulate with out assistance. Mother advised to take child to ER or call EMS should symptoms return. VAERS report completed.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Nausea
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: None
Allergien: None
Vorherige Impfungen: -

VAERS 2313208

MERCK & CO. INC. · HPV (GARDASIL 9) · Charge U008897

mild

Staat: CA
Alter: 35,0
Geschlecht: F
Eingang: 08.06.2022
Impfdatum: 13.05.2022
Beginn: 20.05.2022
Tage bis Beginn: 7,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Arthralgia Injection site pain Joint range of motion decreased Magnetic resonance imaging Scan with contrast X-ray limb

Symptomtext

Pt reports pain in her left upper arm and shoulder; she reports limited range of motion and says she can't reach her arm over her head.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Arthralgia
Hospital-Tage: -
Labordaten: MRI with/without contrast of the Left shoulder has been ordered L shoulder xray has been ordered
Aktuelle Erkrankungen: none
Vorgeschichte: back pain
Andere Medikamente: Vitamin D 50 MCG (2000 UT) Capsule Taking MiraLax Powder Taking Tums Taking Famotidine 10 MG Tablet Taking Sprintec 28 0.25-35 MG-MCG Tablet Taking Ibuprofen 800 MG Tablet Taking diphenhydrAMINE HCl 25 MG Tablet
Allergien: nkda
Vorherige Impfungen: -

VAERS 2214102

MERCK & CO. INC. · HPV (GARDASIL 9) · Charge U008897

mild

Staat: TX
Alter: 25,0
Geschlecht: M
Eingang: 04.04.2022
Impfdatum: 04.04.2022
Beginn: 04.04.2022
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Fatigue Nausea

Symptomtext

Reports he felt nauseated and fatigued.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Fatigue
Hospital-Tage: -
Labordaten: none
Aktuelle Erkrankungen: none
Vorgeschichte: Anxiety and Depression
Andere Medikamente: Zoloft,Bupropion, Trazadone
Allergien: NKA
Vorherige Impfungen: -

VAERS 2213989

MERCK & CO. INC. · HPV (GARDASIL 9) · Charge U008897

mild

Staat: MS
Alter: 27,0
Geschlecht: F
Eingang: 04.04.2022
Impfdatum: 25.03.2022
Beginn: 01.04.2022
Tage bis Beginn: 7,0
Dosis: 3
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Injection site pain

Symptomtext

Left upper arm pains for two weeks

Weitere VAERSDATA-Felder

Praegender Schweregrund: Injection site pain
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: NA
Vorgeschichte: NA
Andere Medikamente: NA
Allergien: Sulfa allergy
Vorherige Impfungen: -

VAERS 2187537

MERCK & CO. INC. · HPV (GARDASIL 9) · Charge U008897

mild

Staat: MI
Alter: 11,0
Geschlecht: F
Eingang: 18.03.2022
Impfdatum: 16.03.2022
Beginn: 16.03.2022
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Pain in extremity

Symptomtext

Arm is a bit sore according to mom

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pain in extremity
Hospital-Tage: -
Labordaten: N/a
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: None
Allergien: None
Vorherige Impfungen: -

VAERS 1999428

MERCK & CO. INC. · HPV (GARDASIL 9) · Charge U008897

mild

Staat: KY
Alter: 18,0
Geschlecht: F
Eingang: 03.01.2022
Impfdatum: 30.12.2021
Beginn: 30.12.2021
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Lymph node pain Lymphadenopathy

Symptomtext

Patient was seen in our office on 12/30/21 and given her flu vaccine and HPV vaccine. After leaving our office she went to Pharmacy and received her covid vaccine in the RA. After receiving that vaccine she developed a golfball size lymph node in her right underarm. Size of lymph node stayed the same but the location changed. The lymph node was very tender to the touch.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Lymph node pain
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2636934

MERCK & CO. INC. · HPV (GARDASIL 9) · Charge U008897

gering

Staat: CA
Alter: -
Geschlecht: U
Eingang: 25.05.2023
Impfdatum: 23.05.2023
Beginn: 23.05.2023
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Expired product administered No adverse event

Symptomtext

No Additional AE; HCP called to report patient received expired dose of GARDASIL 9.; This spontaneous report was received from a licensed vocational nurse and refers to a 12-year-old patient of unknown gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 23-MAY-2023, the patient was vaccinated with expired dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) injection, 0.5 milliliter, lot #U008897, expiration date: 16-MAY-2023, administered for prophylaxis (strength, and route of administration were not provided) (expired product administered). No additional adverse event was reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Expired product administered
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2481745

MERCK & CO. INC. · HPV (GARDASIL 9) · Charge U008897

gering

Staat: MI
Alter: 12,0
Geschlecht: F
Eingang: 18.10.2022
Impfdatum: 09.09.2022
Beginn: 01.09.2022
Tage bis Beginn: -
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Syringe issue

Symptomtext

no adverse events noted. Vaccine leaked around needle hub during administration.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syringe issue
Hospital-Tage: -
Labordaten: na
Aktuelle Erkrankungen: na
Vorgeschichte: hypothyroidism
Andere Medikamente: Levothyroxine 88mcg take one tablet daily.
Allergien: no known allergies
Vorherige Impfungen: -

VAERS 2477164

MERCK & CO. INC. · HPV (GARDASIL 9) · Charge U008897

gering

Staat: MS
Alter: 14,0
Geschlecht: M
Eingang: 13.10.2022
Impfdatum: 18.10.2007
Beginn: 13.10.2022
Tage bis Beginn: 5.474,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Hypoaesthesia

Symptomtext

Numbness right upper arm lateral aspect and base of right thumb since 7:15 am today

Weitere VAERSDATA-Felder

Praegender Schweregrund: Hypoaesthesia
Hospital-Tage: -
Labordaten: none
Aktuelle Erkrankungen: Allergic Rhinitis
Vorgeschichte: Allergic Rhinitis
Andere Medikamente: Singulair 10 mg qd; Zyrtec 10 mg qd and Flonase daily
Allergien: None
Vorherige Impfungen: -

VAERS 2363699

MERCK & CO. INC. · HPV (GARDASIL 9) · Charge U008897

gering

Staat: IA
Alter: -
Geschlecht: U
Eingang: 09.07.2022
Impfdatum: 12.11.2019
Beginn: 17.08.2021
Tage bis Beginn: 644,0
Dosis: 3
Route/Site: - / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Inappropriate schedule of product administration No adverse event

Symptomtext

No additional AE reported; the patient received the doses outside of the recommended administration schedule in the prescribing information; the patient was vaccinated with the third dose on 21-JUN-2022; the patient received the doses outside of the recommended administration schedule in the prescribing information; On 17-AUG-2021, the patient was vaccinated with the second dose; This spontaneous report has been received from a registered nurse (reported as a health care professional (HCP)) and referred to a 14-year-old patient of unknown gender. The patient's concomitant medications, pertinent medical history, and drug reactions/allergies were not reported. On 12-NOV-2019, the patient was vaccinated with the first dose of HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast) (GARDASIL 9) (strength, dose, route, lot#, and expiration date were not reported) for prophylaxis. On 17-AUG-2021, the patient was vaccinated with the second dose of HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast) (GARDASIL 9) (strength, dose, route, lot#, and expiration date were not reported) for prophylaxis (inappropriate schedule of product administration). On 21-JUN-2022, because the HCP was originally unaware that the patient had received doses of HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast) (GARDASIL 9) previously, the patient was vaccinated with the third dose of HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast) (GARDASIL 9) 0.5 ml once (1 dose) at the right upper arm, syringe formulation (valid lot# U008897 with expiration date 16-MAY-2023; strength, and route were not reported) for prophylaxis (inappropriate schedule of product administration). The patient received the doses outside of the recommended administration schedule in the prescribing information (for the patient who started the vaccine before age 15, only 2 doses were needed, however, the patient received 3 doses, and for age 9-14 years old, the 3 doses should be indicated as 2, 4 months intervals). No additional adverse effects were reported (no adverse event). There was no prescription drug treatment for the experience required.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Inappropriate schedule of product administration
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2245458

MERCK & CO. INC. · HPV (GARDASIL 9) · Charge U008897

gering

Staat: CA
Alter: -
Geschlecht: F
Eingang: 21.04.2022
Impfdatum: 08.06.2021
Beginn: -
Tage bis Beginn: -
Dosis: 2
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Inappropriate schedule of product administration No adverse event

Symptomtext

patient got her first dose of GARDASIL 9 on 08-JUN-2021 and got her second dose of GARDASIL 9 on 22-MAR-2022.; No additional AEs reported.; This spontaneous report has been received from a registered nurse and refers to a female patient of unknown age. The patient's current conditions, pertinent medical history, previous drug reactions or allergies and concomitant medications were not provided. On 08-JUN-2021, the patient was vaccinated with the first dose of HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast) (GARDASIL 9) 0.5 milliliter, as prophylaxis (lot number T024831 has been verified to be valid, expiration date 18-NOV-2022); and on 22-MAR-2022, she received the second dose of HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast) (GARDASIL 9) 0.5 milliliter, as prophylaxis (lot number U008897 has been verified to be valid, expiration date 16-MAY-2023) (routes of administrations and anatomical locations of vaccinations were not provided) (inappropriate schedule of product administration). No additional adverse events were reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Inappropriate schedule of product administration
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2152151

MERCK & CO. INC. · HPV (GARDASIL 9) · Charge U008897

gering

Staat: TN
Alter: 18,0
Geschlecht: M
Eingang: 02.03.2022
Impfdatum: 28.02.2022
Beginn: 01.03.2022
Tage bis Beginn: 1,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Erythema Induration Swelling Tenderness

Symptomtext

Local redness, swelling, tenderness induration, measuring 3.5 x 5 inches. Treated with oral steroids, Benadryl & antibiotic. Patient was asked to return to office only if symptoms worsen.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Erythema
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: None
Vorgeschichte: Autistic Disorder, Seizure disorder, Jeavons syndrome,
Andere Medikamente: Clonazepam, divalproex, escitalopram, 10 mg & 5 mg. guanfacine, lamotrigine 100 mg & 25 mg.
Allergien: Penicillin
Vorherige Impfungen: -

VAERS 1957699

MERCK & CO. INC. · HPV (GARDASIL 9) · Charge U008897

gering

Staat: KY
Alter: 21,0
Geschlecht: F
Eingang: 17.12.2021
Impfdatum: 29.11.2021
Beginn: 29.11.2021
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Exposure during pregnancy

Symptomtext

nO ADDITIONAL ADVERSE EVENT REPORTED; consumer received the GARDASIL-9 vaccine while pregnant.; This spontaneous pregnancy report has been received from a nurse via a company representative, referring to a 21 years-old female patient. The last menstrual period was not reported. At the reporting time the patient had 16 gestation weeks. The pregnancy outcome was unknown. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 29-NOV-2021, the patient was vaccinated with a dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) lot # U008897, expiration date on 16-MAY-2023 (anatomical location and administration route were not reported) for prophylaxis. The reporter stated that the patient received the hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) while pregnant. No additional adverse events were reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Exposure during pregnancy
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1931206

MERCK & CO. INC. · HPV (GARDASIL 9) · Charge U008897

gering

Staat: TX
Alter: -
Geschlecht: F
Eingang: 08.12.2021
Impfdatum: -
Beginn: 24.11.2021
Tage bis Beginn: -
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Exposure via blood Occupational exposure to product Syringe issue

Symptomtext

as a result of the broken finger glange the medical assistant cut her finger / the cut was deep enoguth to bleed and need a Band-Aid; Was the product administered or exposed to patient's bodily fluids? Yes, the medical assistant was cut by the broken finger flange; Was the product administered or exposed to patient's bodily fluids? Yes, the medical assistant was cut by the broken finger flange; medical assistant removed the GARDASIL 9 syringe from the tray and discovered the finger flange was broken; This spontaneous report was received from an administrator and refers to a female patient of unknown age, who was also a medical assistant. There was no information regarding her medical history, concurrent condition nor concomitant therapies provided. On 24-NOV-2021, the medical assistant removed HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast) (GARDASIL 9) (0.5 ml, lot # U008897, expiration date 16-MAY-2021) syringe from the tray and discovered the finger flange was broken; 3 pieces of the broken finger flange were found in the tray (discrepant information, also reported as the syringe was broken into less than 2 pieces) (syringe issue). The syringe tray was intact and undamaged on receipt and the syringe carton was not damaged prior to use. The product did not come with a cellophane cover. There was no crack noticed on the syringe. The tip of the syringe and Luer lock adaptor were not loose or broken off of the syringe tip. It was unknown whether there was difficulty trying to attach the syringe needle to the syringe as the medical assistant did not attempt. On 24-NOV-2021, as a result of the broken syringe, the medical assistant cut her finger; the cut was deep enough to bleed and a Band-Aid was needed. It was reported, that exposure to the vaccine via body fluid occurred (occupational exposure to product, exposure via blood). No additional medical attention was needed for the cut. At the time of the report, the medical assistant was recovering from the finger cut. The reporter confirmed the HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast) (GARDASIL 9) was not administered to a patient. The causal relationship between the event and the suspect vaccine was not reported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Exposure via blood
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -